Back to funds
View filing
Nicholas Investment Partners, LP
hedge fundUpdated 27 days agoManaged by Nicholas Investment Partners, Lp • Latest filing Q2 2026
Portfolio value
$1.8B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
1.7%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.3B |
| Q2 2023 | $1.5B |
| Q3 2023 | $1.3B |
| Q4 2023 | $854.6M |
| Q1 2024 | $976.3M |
| Q2 2024 | $963.9M |
| Q3 2024 | $1.1B |
| Q4 2024 | $1.1B |
| Q1 2025 | $971.1M |
| Q2 2025 | $1.1B |
| Q3 2025 | $1.3B |
| Q4 2025 | $1.4B |
| Q1 2026 | $1.4B |
| Q2 2026 | $1.8B |
Top holdings
204 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | B BWXT BWX TECHNOLOGIES INC | $53M | 272.4K | 2.99% | — |
| 2 | R RVMDW REVOLUTION MEDICINES INC | $45.8M | 244.6K | 2.58% | — |
| 3 | C CALY CALLAWAY GOLF CO | $36.7M | 1.95M | 2.07% | — |
| 4 | M MOD MODINE MFG CO | $29.7M | 111.3K | 1.67% | — |
| 5 | C CRS CARPENTER TECHNOLOGY CORP | $26.9M | 43.7K | 1.52% | — |
| 6 | L LINC LINCOLN EDL SVCS CORP | $26.5M | 531.9K | 1.50% | — |
| 7 | N NVDA NVIDIA CORPORATION | $25.3M | 126.7K | 1.43% | — |
| 8 | S STRL STERLING INFRASTRUCTURE INC | $25.3M | 30.1K | 1.42% | — |
| 9 | A AXSM AXSOME THERAPEUTICS INC. | $24.2M | 99.0K | 1.36% | — |
| 10 | G GEV GE VERNOVA INC | $24.1M | 20.5K | 1.36% | — |
| 11 | X XENE XENON PHARMACEUTICALS INC | $23.9M | 395.8K | 1.35% | — |
| 12 | B BBIO BRIDGEBIO PHARMA INC | $23.2M | 311.5K | 1.31% | — |
| 13 | L LSCC LATTICE SEMICONDUCTOR CORP | $22.4M | 146.3K | 1.26% | — |
| 14 | K KTB KONTOOR BRANDS INC | $21.8M | 261.1K | 1.23% | — |
| 15 | T TSMWF TAIWAN SEMICONDUCTOR MANUFAC | $21.5M | 44.9K | 1.21% | — |
| 16 | S STX SEAGATE HDD CAYMAN | $21.2M | 1.82M | 1.20% | — |
| 17 | W WTFCN WINTRUST FINL CORP | $20.9M | 130.3K | 1.18% | — |
| 18 | S SITM SITIME CORP | $20.5M | 27.6K | 1.16% | — |
| 19 | T TFII TFI INTERNATIONAL INC | $20.3M | 141.2K | 1.14% | — |
| 20 | M MIRM MIRUM PHARMACEUTICALS INC | $20.2M | 172.7K | 1.14% | — |